HCA:NYE-HCA Holdings Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 376.59

Change

0.00 (0.00)%

Market Cap

USD 26.31B

Volume

1.14M

Analyst Target

USD 147.05
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
THC Tenet Healthcare Corporation

+2.12 (+1.30%)

USD 15.37B
UHS Universal Health Services Inc

+6.21 (+3.33%)

USD 12.76B
EHC Encompass Health Corp

+2.11 (+1.77%)

USD 12.18B
DVA DaVita HealthCare Partners Inc

+1.70 (+1.23%)

USD 11.16B
CHE Chemed Corp

+11.62 (+2.04%)

USD 8.48B
CON Concentra Group Holdings Paren..

+0.40 (+1.89%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.25 (+1.71%)

USD 2.59B
NHC National HealthCare Corporatio..

+2.12 (+2.07%)

USD 1.68B
BKD Brookdale Senior Living Inc

+0.18 (+2.81%)

USD 1.61B
GRDN Guardian Pharmacy Services, In..

+0.19 (+0.87%)

USD 1.25B

ETFs Containing HCA

ZWHC:CA BMO Covered Call Health C.. 4.84 % 0.00 %

+0.41 (+1.30%)

N/A
WBIL WBI BullBear Quality 3000.. 4.77 % 1.07 %

+0.40 (+1.30%)

USD 0.03B
DXSP:XETRA Xtrackers - Euro Stoxx 50.. 4.68 % 0.00 %

-0.03 (1.30%)

USD 0.05B
BWTG Brendan Wood TopGun ETF 4.49 % 0.00 %

+0.49 (+1.30%)

USD 0.01B
YALL God Bless America ETF 4.46 % 0.00 %

+0.68 (+1.30%)

N/A
MHG:AU Magellan Global Equities 4.24 % 0.00 %

-0.03 (1.30%)

USD 0.10B
MGE:AU 4.11 % 0.00 %

N/A

N/A
LSAT Two Roads Shared Trust - .. 3.55 % 0.00 %

-0.18 (1.30%)

USD 0.10B
COWS Amplify Cash Flow Dividen.. 2.86 % 0.00 %

+0.60 (+1.30%)

USD 0.02B
HCOW Amplify Cash Flow High In.. 2.81 % 0.00 %

+0.51 (+1.30%)

USD 9.23M
FEGE The RBB Fund Trust 2.51 % 0.00 %

+0.50 (+1.30%)

N/A
XHS SPDR® S&P Health Care Se.. 2.30 % 0.35 %

+1.51 (+1.30%)

USD 0.09B
RSPH Invesco S&P 500 Equal Wei.. 2.00 % 0.00 %

+0.54 (+1.30%)

USD 0.75B
XLVE:CA 1.79 % 0.00 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.52 % 0.39 %

+0.40 (+1.30%)

CAD 0.21B
ZHU:CA BMO Equal Weight US Healt.. 1.52 % 0.00 %

+0.95 (+1.30%)

CAD 0.01B
FLDZ Listed Funds Trust 0.53 % 0.00 %

+0.43 (+1.30%)

USD 3.91M
EUSA iShares MSCI USA Equal We.. 0.22 % 0.15 %

+1.69 (+1.30%)

USD 1.46B
XEWG:LSE Xtrackers S&P 500 Equal W.. 0.22 % 0.00 %

-832.64 (1.30%)

USD 0.11B
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.22 % 0.00 %

+0.08 (+1.30%)

USD 12.74B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.44 (+1.30%)

N/A
NASH 0.00 % 0.49 %

N/A

N/A
PKW Invesco BuyBack Achievers.. 0.00 % 0.62 %

+2.36 (+1.30%)

USD 1.15B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.11 (+1.30%)

CAD 0.10B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
CHGX Change Finance Diversifie.. 0.00 % 0.64 %

+0.43 (+1.30%)

USD 0.14B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.47% 76% C+ 95% A
Dividend Return 0.24% 44% F 7% C-
Total Return 25.71% 76% C+ 95% A
Trailing 12 Months  
Capital Gain 18.16% 81% B- 85% B
Dividend Return 0.85% 44% F 17% F
Total Return 19.01% 82% B 84% B
Trailing 5 Years  
Capital Gain 231.33% 94% A 92% A
Dividend Return 9.03% 50% F 22% F
Total Return 240.36% 94% A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 27.10% 91% A- 89% A-
Dividend Return 28.04% 91% A- 88% B+
Total Return 0.94% 40% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 33.65% 48% F 26% F
Risk Adjusted Return 83.35% 100% F 89% A-
Market Capitalization 26.31B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.50 41% 51%
Price/Book Ratio 293.44 5% 1%
Price / Cash Flow Ratio 8.62 45% 44%
Price/Free Cash Flow Ratio 9.66 53% 51%
Management Effectiveness  
Return on Equity 16.06% 63% 79%
Return on Invested Capital 22.16% 90% 91%
Return on Assets 11.61% 94% 95%
Debt to Equity Ratio -1,533.93% 100% 99%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.